--- title: "Pre-market hot trades in US stocks: Adagio Medical pre-market down 14.93%; Arista Networks pre-market up 13.38%" type: "News" locale: "en" url: "https://longbridge.com/en/news/294931434.md" description: "Adagio Medical pre-market down 14.93%; Arista Networks pre-market up 13.38%; C3is pre-market up 53.01%; Bluejay Diagnostics pre-market up 47.96%; Zhongjin Medical pre-market up 47.04%" datetime: "2026-08-05T08:18:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294931434.md) - [en](https://longbridge.com/en/news/294931434.md) - [zh-HK](https://longbridge.com/zh-HK/news/294931434.md) generator: "portal-rs" --- # Pre-market hot trades in US stocks: Adagio Medical pre-market down 14.93%; Arista Networks pre-market up 13.38% **Pre-market Hot Trades in US Stocks** Adagio Medical is down 14.93% in pre-market trading. Based on recent key news: 1. On August 4, Adagio Medical had a market capitalization of approximately $10.17 million, with its stock price falling about 66.42% over the past 12 months. Benzinga Edge's stock rankings indicate negative price trends in the short, medium, and long term, leading to a significant drop in stock price. 2. On August 3, Adagio Medical Holdings Inc. announced that the company would continue to update its forward-looking statements but would not assume any obligation to update them. This increased market uncertainty regarding the company's future performance, further pressuring the stock price. 3. On August 3, a news brief released by Adagio Medical Holdings Inc. through Business Wire indicated that the company had performed poorly over the past year, exacerbating investor concerns. The overall market performance is weak, and capital flows are unstable. Arista Networks is up 13.38% in pre-market trading. Based on recent key news: 1. On August 4, Arista Networks reported its second-quarter earnings, with profits and revenue exceeding expectations. The company achieved a profit of $1.21 billion, with earnings per share of $0.95, and adjusted earnings per share of $1.02, with revenue growing 38% to $3.04 billion. The stock price rose 12% in after-hours trading to $214. 2. On August 4, Arista Networks forecasted that third-quarter revenue would exceed Wall Street expectations, with adjusted earnings per share expected to be between $1.06 and $1.08, and revenue around $3.3 billion. The stock price rose 3% in after-hours trading. 3. On August 4, several analysts raised their target price for Arista Networks to a range of $190 to $200, maintaining buy or overweight ratings. Demand for AI infrastructure is strong, and the industry outlook is optimistic. **Top Gainers in Pre-market US Stocks** C3is is up 53.01% in pre-market trading. Based on recent key news: 1. On August 4, C3is conducted two reverse stock splits in early 2026 to maintain listing qualifications while actively acquiring tankers, achieving a 358% increase in adjusted net income in the first quarter. This series of aggressive moves led to significant stock price volatility, reflecting the market's reaction to its high-risk, high-reward strategy. The market has reacted strongly to the high-risk strategy. Bluejay Diagnostics is up 47.96% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Zhongjin Medical is up 47.04% in pre-market trading. Based on recent key news: 1. On August 4th, Zhongjin Medical announced its latest business developments and market strategies, leading to a significant increase in its stock price. The positive development plans mentioned in the announcement boosted investor confidence, resulting in a substantial rise in the stock price during pre-market trading. 2. On August 5th, technical sentiment signals indicated a strong sell, yet the market's optimism towards Zhongjin Medical continued to drive the stock price up. Despite technical indicators showing sell signals, investors' optimistic expectations for the company's future prospects may be one of the reasons for the stock price increase. 3. Recently, the market's attention towards Zhongjin Medical has increased, with trading volume significantly rising. The average trading volume was 279,315, indicating growing market interest in the stock, further propelling the stock price upward. The market's attention towards Zhongjin Medical has increased ### Related Stocks - [ADGM.US](https://longbridge.com/en/quote/ADGM.US.md) - [ANET.US](https://longbridge.com/en/quote/ANET.US.md) - [CISS.US](https://longbridge.com/en/quote/CISS.US.md) - [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md) - [ZJYL.US](https://longbridge.com/en/quote/ZJYL.US.md) ## Related News & Research - [Arista Networks President, CTO Kenneth Duda disposes of USD 3.87 million in common shares](https://longbridge.com/en/news/296833611.md) - [Oakwell Private Wealth Management LLC Invests $1.49 Million in Arista Networks, Inc. $ANET](https://longbridge.com/en/news/295999681.md) - [Adagio Medical treats first patient with next-generation vCLAS Ultra ULTA system under FDA expanded access](https://longbridge.com/en/news/294693443.md) - [ANET: Record Q2 revenue and EPS growth, with strong outlook and new AI platform launches](https://longbridge.com/en/news/294865573.md) - [Stableford Capital II LLC Purchases New Shares in Arista Networks, Inc. $ANET](https://longbridge.com/en/news/294805804.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**